FLNA
Filana Therapeutics, Inc. NASDAQ Listed Jul 14, 2000$1.44
After hrs
$1.42
-1.39%
Mkt Cap $69.6M
52w Low $1.35
2.5% of range
52w High $4.98
50d MA $1.83
200d MA $2.45
P/E (TTM)
-0.8x
EV/EBITDA
-0.0x
P/B
1.0x
Debt/Equity
0.0x
ROE
-122.3%
P/FCF
-3.0x
RSI (14)
—
ATR (14)
—
Beta
-0.68
50d MA
$1.83
200d MA
$2.45
Avg Volume
546.2K
About
Filana Therapeutics, Inc. engages in the development of novel drugs and diagnostics. It focuses on developing product candidates intended for the treatment of Alzheimer’s disease, including PTI-125 and PTI-125Dx. The company was founded by Remi Barbier in May 1998 and is headquartered in Austin, TX.
Recent Earnings
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 12, 2026 | AMC | -0.30 | -0.26 | +13.3% | 1.95 | +4.6% | +2.1% | +0.0% | +2.6% | -2.1% | -6.2% | — |
Recent Filings
8-K
Unknown — 8-K Filing
Filana's net loss nearly quadrupled year-over-year to $91 million, signaling aggressive R&D spending or operational challenges that could pressure the stock unless upcoming clinical data justifies the burn rate.
Mar 12
8-K · 5.03
! Medium
Unknown — 8-K 5.03: Amendment to Articles / Bylaws
Fleetwood Enterprises (FLNA) updated its investor relations website location, a minor operational change that doesn't materially affect business fundamentals or valuation.
Mar 10
8-K · 8.01
!! High
Filana Therapeutics, Inc. -- 8-K 8.01: Material Event / Announcement
I cannot provide a meaningful analysis because the summary does not contain specific information about what material event or announcement occurred for Filana Therapeutics.
Feb 19
Data updated apr 25, 2026 9:21am
· Source: massive.com